Cite
HARVARD Citation
Vodicka, P. et al. (2022). Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world. European journal of haematology. pp. 162-165. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vodicka, P. et al. (2022). Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world. European journal of haematology. pp. 162-165. [Online].